Successful treatment of cryptococcal meningitis with intraventricular miconazole.
A patient with cryptococcal meningitis retractory to amphotericin B was treated primarily with intraventricular miconazole. All parameters of disease improved, and the patient was dischared after four months of therapy. In selected persons with cryptococcosis, it may be possible to successfully utilize intraventricular miconazole in the absence of concurrent intravenous medication.
D000666:Amphotericin B / Q000627:therapeutic use; D003453:Cryptococcosis / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007276:Injections, Intraventricular; D008297:Male; D008581:Meningitis / Q000188:drug therapy*; D008825:Miconazole / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged
D007093:Imidazoles; D008825:Miconazole; D000666:Amphotericin B